39 studies found for:    " January 14, 2009":" February 13, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" January 14, 2009":" February 13, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (39 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Unknown  Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring
Conditions: Human Immunodeficiency Virus;   HIV Infections
Interventions: Drug: Reducing dose of Lopinavir;   Drug: Reducing dose of efavirenz
2 Completed Video-based Counseling & Rapid HIV Testing for Teens
Conditions: HIV;   HIV Infections
Interventions: Behavioral: Video;   Behavioral: in-person HIV pre-test counseling
3 Unknown  A Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication
Conditions: HIV-1;   HIV Infections
Interventions: Other: VircoType HIV-1 genotypic interpretation;   Other: Local Expert Review of HIV Genotypic resistance testing
4 Unknown  Positive Lifestyles Using Safety
Conditions: HIV;   HIV Infections
Interventions: Behavioral: Pre-Release (Group 1);   Behavioral: Post-release (Group 2)
5 Active, not recruiting
Has Results
Behavioral Intervention to Reduce Sexual and Injection Risks Among Female Sex Workers Who Also Inject Drugs in Mexico
Conditions: HIV;   HIV Infections
Interventions: Behavioral: Interactive injection and sexual risk intervention;   Behavioral: Interactive Sexual Risk Intervention;   Behavioral: Interactive Injection Risk Intervention
6 Completed
Has Results
A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients
Condition: Human Immunodeficiency Virus Type 1
Interventions: Drug: TMC310911 75 mg twice daily;   Drug: TMC310911 150 mg twice daily;   Drug: TMC310911 300 mg twice daily;   Drug: TMC310911 300 mg once daily;   Drug: Ritonavir 100 mg twice daily;   Drug: Ritonavir 100 mg once daily
7 Completed Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV
Conditions: HIV;   HIV Infections
Interventions: Biological: ZFN modified T cells;   Other: Structured Treatment Interruption
8 Completed Transitions: Linkages From Jail To Community
Conditions: HIV;   Substance Abuse;   HIV Infections
Interventions: Behavioral: Intensive Case Management;   Drug: Buprenorphine;   Behavioral: Money Management
9 Completed Study of Impacts of Food Supplementation on Malnourished HIV-Infected Adults in Kenya
Conditions: HIV;   Malnutrition;   HIV Infections
Interventions: Dietary Supplement: fortified blended flour - Insta Foundation Plus (with whey protein concentrate);   Other: nutrition counseling
10 Completed Acupuncture/Moxibustion (Acu/Moxa) for Distal Symmetric Peripheral Neuropathy (DSP) in HIV
Conditions: Peripheral Neuropathy;   HIV;   AIDS;   HIV Infections
Interventions: Other: Acupuncture / Moxibustion;   Other: Acupuncture/Moxibustion
11 Completed Cell Phone Intervention to Support Antiretroviral Therapy (ART) Adherence in Kenya
Conditions: HIV;   AIDS;   HIV Infections
Intervention: Other: Cell Phone Intervention
12 Active, not recruiting Alveolar Macrophage Proteomics in HIV-associated Emphysema
Conditions: HIV;   Emphysema;   HIV Infections
Intervention:
13 Active, not recruiting Effect of Raltegravir on Endothelial Function in HIV-Infected Patients
Conditions: HIV Infection;   Inflammation;   Cardiovascular Disease;   HIV Infections
Interventions: Drug: raltegravir;   Drug: Placebo
14 Active, not recruiting Epidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension
Conditions: HIV Infection;   Pulmonary Hypertension;   Endothelial Function;   HIV Infections
Intervention:
15 Active, not recruiting A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects
Conditions: HIV-1 Infection;   HIV Infections
Interventions: Biological: mRNA-transfected autologous dendritic cells;   Biological: Autologous dendritic cells not transfected with mRNA.
16 Completed ID and Testing Via Friendship Networks
Conditions: Asymptomatic HIV;   HIV Infections
Interventions: Other: Index Recruiter;   Other: Friendship Network Member
17 Completed
Has Results
A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients
Condition: Human Immunodeficiency Virus-1
Intervention: Drug: maraviroc
18 Completed
Has Results
Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants
Conditions: Human Immunodeficiency Virus Type 1 (HIV-1);   HIV Infections
Interventions: Drug: Voriconazole;   Drug: Atazanavir;   Drug: Ritonavir
19 Completed
Has Results
Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Other: Placebo;   Biological: TUTI-16 (0.03mg);   Biological: TUTI-16 (0.1mg);   Biological: TUTI-16 (0.6mg)
20 Recruiting Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.
Condition: HIV Infections
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results
Indicates status has not been verified in more than two years